Evaluation the efficacy of a syrup of Echium amoenum-Melissa officinalis in treatment of adolescents with Obsessive-Compulsive Disorder

Phase 3

• Conditions: F42.2; Obsessive-Compulsive Disorder.; Mixed obsessional thoughts and acts

• Registration Number: IRCT20191127045521N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Obsessive-Compulsive Disorder with a diagnosis of pediatric psychiatry according to DSM-5 criteria
Ages 13 to 17 years

Exclusion Criteria

Psychosis
Bipolar disorder
Catatonic symptoms
Drug abuse
Severe or debilitating illnesses
Phenobarbital consumption
Oxazepam consumption
Sedative drugs consumption

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Obsessive score on children's Yale-Brown Obsessive Compulsive questionnaire. Timepoint: pretest, 4 weeks after beginning, post-test (at the end of 8 weeks). Method of measurement: children's Yale-Brown Obsessive Compulsive questionnaire.

Secondary Outcome Measures

Name	Time	Method
Quality of life score. Timepoint: pretest, post-test (at the end of 8 weeks). Method of measurement: The World Health Organization Quality of Life Questionnaire.;Anxiety score. Timepoint: pretest, 4 weeks after beginning, post-test (at the end of 8 weeks). Method of measurement: Spence Children's Anxiety Questionnaire.;Depression score. Timepoint: pretest, 4 weeks after beginning, post-test (at the end of 8 weeks). Method of measurement: Maria Kovas Depression Questionnaire.